Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK315234A in Active Rheumatoid Arthritis
NCT00674635Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2008
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of GSK315234 in rheumatoid arthritis (RA), sponsored by GSK. Started Apr 2008; status: completed.
02
Drugs
GSK315234
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00674635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674635.